Cas9-recombinase fusion proteins and uses thereof
Some aspects of this disclosure provide compositions, methods, and kits for improving the specificity of RNA-programmable endonucleases, such as Cas9. Also provided are variants of Cas9, e.g., Cas9 dimers and fusion proteins, engineered to have improved specificity for cleaving nucleic acid targets. Also provided are compositions, methods, and kits for site-specific recombination, using Cas9 fusion proteins (e.g., nuclease-inactivated Cas9 fused to a recombinase catalytic domain). Such Cas9 variants are useful in clinical and research settings involving site-specific modification of DNA, for example, genomic modifications.
1. A dimer or tetramer of a fusion protein wherein the fusion protein comprises two domains: (i) a nuclease-inactivated Cas9 (dCas9); and (ii) a recombinase catalytic domain;
wherein the nuclease-inactivated Cas9 domain is bound to a guide RNA (gRNA); and
wherein the dimer or the tetramer is bound to a nucleic acid.
2. The dimer or tetramer of a fusion protein of claim 1 , wherein the recombinase catalytic domain is a monomer of the recombinase catalytic domain of Hin recombinase, Gin recombinase, or Tn3 recombinase.
3. The dimer or tetramer of a fusion protein of claim 1 , further comprising a nuclear localization signal (NLS) domain.
4. The dimer or tetramer of a fusion protein of claim 3 , wherein one or more domains of the fusion protein are separated by a peptide linker or a non-peptide linker.
5. The dimer or tetramer of a fusion protein of claim 4 , wherein the peptide linker comprises an XTEN linker, an amino acid sequence comprising one or more repeats of the tri-peptide GGS, or any sequence as provided in FIG. 12A (SEQ ID NOs: 14-25 and 301).
6. The dimer of the fusion protein of claim 1 , wherein each fusion protein of the dimer is bound to opposite strands of the nucleic acid.
7. A kit comprising a dimer or tetramer of a fusion protein of claim 1 .